4,633 results on '"A. Nicolas"'
Search Results
2. Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
3. NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients
4. Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias
5. The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis
6. Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia
7. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
8. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study
9. The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients
10. Genetic engineering of transfusable platelets with mRNA-lipid nanoparticles is compatible with blood banking practices
11. Hemostasis defects underlying the hemorrhagic syndrome caused by mammarenaviruses in a cynomolgus macaque model
12. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study
13. CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
14. Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity
15. Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death
16. Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors
17. IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition
18. DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity
19. Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
20. Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis
21. Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity
22. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study
23. Modulation of human thrombopoietin receptor conformations uncouples JAK2 V617F-driven activation from cytokine-induced activation
24. A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia
25. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation
26. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study
27. KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target
28. Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse
29. Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
30. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
31. Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL
32. Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL
33. Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study
34. Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
35. Granulocyte microvesicles with a high plasmin generation capacity promote clot lysis and improve outcome in septic shock
36. Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study
37. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal
38. Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis
39. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
40. Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia
41. High frequency of clonal hematopoiesis in Erdheim-Chester disease
42. Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia
43. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
44. Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment
45. FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus
46. Impact of Arsenic Trioxide in the Treatment of Higher Risk Acute Promyelocytic Leukemia
47. Secondary Acute Myeloid Leukemia from a Previous Chronic Myeloproliferative Neoplasm: A Study of Grelam-Chile Concerning Chilean Patients on Behalf of AML Pethema Registry
48. Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry
49. Clonal Dynamics of FLT3-ITD Positive Acute Myeloid Leukemia Patients with Relapsed/Refractory Disease Following Intensive Chemotherapy +/- Midostaurin
50. Mutational Profile and Dynamics of PPM1D-Mutant Clones in the Spectrum of Myeloid Disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.